The recent literature is filled with trials of type II diabetes (DM) treatment and cardiovascular (CV) disease, with conflicting conclusions. While intuitively reasonable, not all trials of intensive glucose management in diabetes have been found to reduce CV events nor decrease CV mortality.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content